project id: TCGA-STAD; case submitter id: TCGA-B7-A5TK; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.39; rna integrity number: 7.3; age at index: 51; days to birth: -18750; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1961; age at diagnosis: 18750; ajcc pathologic m: M0; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T4; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 288.0; icd 10 code: C16.1; last known disease status: not reported; morphology: 8144/3; primary diagnosis: Adenocarcinoma, intestinal type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Fundus of stomach; synchronous malignancy: No; tissue or organ of origin: Fundus of stomach; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 51; initial weight: 110.0; sample id: 58937d2c-b4c3-4992-a95c-d0d1fa73f1a9; sample submitter id: TCGA-B7-A5TK-01A; portion id: 0a88b5ee-a902-40bf-bae0-d24af807f9d9; portion submitter id: TCGA-B7-A5TK-01A-12; slide id: 1af67108-e8c9-4d72-8800-269630b58c4c; slide submitter id: TCGA-B7-A5TK-01A-01-TSA; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 2.0; percent necrosis: 2.0; percent neutrophil infiltration: 2.0; percent normal cells: 0.0; percent stromal cells: 40.0; percent tumor cells: 58.0; percent tumor nuclei: 75.0; section location: TOP;